Alliqua BioMedical to acquire Adynxx, forming new clinical-stage pharmaceutical leader

pharmanewsdaily- October 25, 2018

Pennsylvania-based Alliqua BioMedical has announced a significant merger with San Francisco's Adynxx, aiming to establish a clinical-stage pharmaceutical entity dedicated to non-opioid pain management therapies. ... Read More